{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Recombinant Growth Factor[C530]" in comments (approximate match)
Class (Stereo):
CHEMICAL (ABSOLUTE)
Semparatide (previously known as RS-66271) was developed as an analog of parathyroid hormone-related protein (PTHrP) with shortening the time for fracture healing. Experiments on animals have shown that this compound was an effective therapy for preventing impaired bone healing caused by prednisone. Clinical trials with postmenopausal osteoporotic women have revealed that semparatide cause sustained increases in the spine. However, further, development appears to have been discontinued by Roche.
Status:
US Approved Rx
(2023)
Source:
BLA761134
(2023)
Source URL:
First approved in 2023
Source:
BLA761134
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2022)
Source:
BLA761148
(2022)
Source URL:
First approved in 2022
Source:
BLA761148
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2008)
Source:
BLA125268
(2008)
Source URL:
First approved in 2008
Source:
BLA125268
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2005)
Source:
BLA021839
(2005)
Source URL:
First approved in 2005
Source:
BLA021839
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2004)
Source:
BLA125103
(2004)
Source URL:
First approved in 2004
Source:
BLA125103
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2022)
Source:
BLA761173
(2022)
Source URL:
First approved in 2002
Source:
BLA125031
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2001)
Source:
BLA103951
(2001)
Source URL:
First approved in 2001
Source:
BLA103951
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1997)
Source:
BLA103691
(1997)
Source URL:
First approved in 1997
Source:
BLA103691
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(1991)
Source:
BLA103362
(1991)
Source URL:
First approved in 1991
Source:
BLA103362
Source URL:
Class:
PROTEIN
